Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Novartis AG
  6. News
  7. Summary
    NOVN   CH0012005267

NOVARTIS AG

(NOVN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about NOVARTIS AG
10/21NOVARTIS : COVID-19 news feed
PU
10/21Novartis Signs New Deal With BioNTech to Support Production of Covid-19 Vaccine
MT
10/21Novartis Expands Fill-and-Finish Deal with BioNTech for COVID-19 Jabs
MT
10/21NOVARTIS : signs new initial agreement with BioNTech to support fill and finish of the mRN..
PU
10/21NOVARTIS : extends deal to make Pfizer/BioNTech vaccines
RE
10/20Novartis in New Agreement With BioNTech to Help Manufacture Covid-19 Vaccine
DJ
10/20NOVARTIS : Global Heart Hub Roll Out Improvement Program For Cardiovascular Disease Manage..
MT
10/19NOVARTIS : Global Heart Hub and Novartis partner to tackle ASCVD, a global health crisis a..
PU
10/19PRESS RELEASE : Global Heart Hub and Novartis -2-
DJ
10/19Global Heart Hub and Novartis partner to tackle ASCVD, a global health crisis and world..
DJ
10/19PRESS RELEASE : Global Heart Hub and Novartis partner to tackle ASCVD, a global health cri..
DJ
10/14NOVARTIS AG : Goldman Sachs reiterates its Buy rating
MD
10/14NOVARTIS' : Kesimpta Shows Stable Antibody Levels in Patients of Phase 3b Extension Study
MT
10/14NOVARTIS : Says Diabetic Macular Edema Drug Applications Accepted by FDA, EMA
MT
10/14NOVARTIS' : Multiple Sclerosis Therapy Shows Preservation of Immunoglobulin Levels in Rela..
MT
More most relevant news
All news about NOVARTIS AG
10/22PRESS RELEASE : FDA approves Roche's Susvimo, a -2-
DJ
10/22Creatd Shares Jump After Unit Signs Alexis LaRue
DJ
10/21BIONTECH : Shares Rise After Data Shows Efficacy of COVID-19 Vaccine's Booster Dose
MT
10/21GLOBAL MARKETS LIVE : Tesla, Unilever, Paypal, Elliott, Novartis...
10/21NOVARTIS : COVID-19 news feed
PU
10/21Novartis Signs New Deal With BioNTech to Support Production of Covid-19 Vaccine
MT
10/21Novartis Expands Fill-and-Finish Deal with BioNTech for COVID-19 Jabs
MT
10/21NOVARTIS : signs new initial agreement with BioNTech to support fill and finish of the mRN..
PU
10/21NOVARTIS : extends deal to make Pfizer/BioNTech vaccines
RE
10/20Novartis in New Agreement With BioNTech to Help Manufacture Covid-19 Vaccine
DJ
More news
News in other languages on NOVARTIS AG
10/22WDH : Roche erhält US-Zulassung für Augenimplantat Susvimo
10/22L'agenda della prossima settimana
10/22AKTIEN SCHWEIZ SCHLUSS : SMI verteidigt die 12'000 Punkte
10/22BEURSAGENDA : buitenlandse fondsen
10/22BOURSE ZURICH : toujours à la recherche d'une direction en fin de matinée
10/22BOURSE ZURICH : la confiance vacille dans les premiers échanges
10/22BOURSE ZURICH : optimisme de mise en fin de semaine
10/22Morning Briefing - Markt Schweiz
10/22BEURSAGENDA : buitenlandse fondsen
10/224-Wochenvorschau Schweiz
More news
Analyst Recommendations on NOVARTIS AG
10/14NOVARTIS AG : Goldman Sachs reiterates its Buy rating
MD
10/12NOVARTIS AG : Bernstein sticks Neutral
MD
10/11ANALYST RECOMMANDATIONS : AstraZeneca, Comcast, Exxon, Starbucks...
10/11NOVARTIS : Berenberg Lowers Price Target on Novartis, Maintains Buy Recommendation
MT
10/11NOVARTIS AG : Berenberg reaffirms its Buy rating
MD
More recommendations
Press releases
10/21NOVARTIS : COVID-19 news feed
PU
10/21NOVARTIS : signs new initial agreement with BioNTech to support fill and finish of the mRN..
PU
10/19NOVARTIS : Global Heart Hub and Novartis partner to tackle ASCVD, a global health crisis a..
PU
10/14NOVARTIS : Kesimpta® (ofatumumab) data at ECTRIMS highlights preservation of IgG levels an..
PU
10/13NOVARTIS : announces FDA and EMA filing acceptances of Beovu® for patients with diabetic m..
PU
More press releases
Upcoming event on NOVARTIS AG